Trials / Terminated
TerminatedNCT02617095
Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy and safety of T2762 versus Optive® in the treatment of moderate to severe Dry Eye Syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | T2762 | One drop in each eye 3 to 6 times daily |
| DEVICE | Optive | One drop in each eye 3 to 6 times daily |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2016-06-01
- Completion
- 2016-10-01
- First posted
- 2015-11-30
- Last updated
- 2017-03-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02617095. Inclusion in this directory is not an endorsement.